The concept of innovative drugs is active again, Shen Lian Biomedical has achieved a two-day limit up
In the morning session, the innovative drug concept became active again, with Shen Lian Biomedical hitting a two-day limit up, Furui Co., Ltd. reaching a 20% limit up, and HYBIO, Sun-Novo, SHANGHAI YIZHONG, and Sunshine Guojian Pharmaceutical rising over 5%. According to news, the "China Innovative Drug and Medical Device Multi-Payment White Paper" shows that the estimated scale of China's innovative drug and medical device market will be about 162 billion yuan in 2024. The white paper predicts that by 2035, the market size of innovative drugs and medical devices in China will exceed 1 trillion yuan